vimarsana.com

Page 6 - Pointr Data Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

DGAP-News: Oncotelic s Dr Anthony Maida to Present at 2nd Annual TGF-β for Immuno-Oncology Drug Development Summit in January 2022

DGAP-News: Oncotelic Therapeutics Oncotelic s Dr. Anthony Maida to Present at 2nd Annual TGF-β for Immuno-Oncology Drug Development Summit in January 2022 14.12.2021 / 15:01 The issuer is solely responsible for the content of this announcement. Oncotelic Therapeutics, Inc. (Oncotelic or the C.

United statesAnthony maidaAmit shahVuong trieuClinical officeOncology drug development summitPointr data incOxigene incDistribution servicesOncotelic therapeutics incMateon therapeutics incNews serviceMateon therapeutics inc oncotelicOncotelic therapeuticsImmuno oncology drug development summitChief clinical officer

Oncotelic s Dr Anthony Maida to Present at 2nd Annual TGF-β for Immuno-Oncology Drug Development Summit in January 2022

Press release content from News Direct Corporation. The AP news staff was not involved in its creation.

Anthony maidaAmit shahVuong trieuClinical officeOncology drug development summitPointr data incOxigene incOncotelic therapeutics incMateon therapeutics incMateon therapeutics inc oncotelicChief clinical officerBoard directorImmuno oncology drug development summitChief clinical officeMestag therapeuticsMateon therapeutics

Investegate |Oncotelic Therapeutics Announcements | Oncotelic Therapeutics: ONCOTELIC ANNOUNCES POSITIVE TOPLINE DATA FOR OT-101 C001 COVID STUDY

Investegate announcements from Oncotelic Therapeutics, ONCOTELIC ANNOUNCES POSITIVE TOPLINE DATA FOR OT-101 C001 COVID STUDY

Amit shahOncotelic therapeutics incCompany websiteMateon therapeutics incPointr data incMateon therapeutics inc oncotelicCenter studyOxigene incOncotelic therapeuticsStudy dataAnalysis data modelsPlacebo controlledMulti center studyPrivate securities litigation reform actMateon therapeuticsNew york

vimarsana © 2020. All Rights Reserved.